THE KPM GROUP DC LLC

Lobbying for REZOLUTE · clinical stage biopharmaceutical company creating therapies for metabolic diseases

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $40,000.00 income · posted Jul 28, 2026

Lobbying activity 1

Pharmacy

General health issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem